Us Bancorp \De\ Novo Nordisk A S Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Novo Nordisk A S stock. As of the latest transaction made, Us Bancorp \De\ holds 366,835 shares of NVO stock, worth $37.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

366,835

Previous 366,604 0.06%

Holding current value

$37.3 Million

Previous $52.3 Million 16.53%

% of portfolio

0.06%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$119.07 - $145.42 $27,505 - $33,592	231 Added 0.06%	366,835 $43.7 Million
Q2 2024 Aug 06, 2024	SELL	$122.71 - $146.91 $3.38 Million - $4.05 Million	-27,578 Reduced 7.0%	366,604 $52.3 Million
Q1 2024 May 07, 2024	SELL	$102.11 - $135.92 $1.17 Million - $1.56 Million	-11,488 Reduced 2.83%	394,182 $50.6 Million
Q4 2023 Feb 09, 2024	BUY	$87.78 - $105.45 $1.03 Million - $1.24 Million	11,729 Added 2.98%	405,670 $42 Million
Q3 2023 Nov 03, 2023	BUY	$90.94 - $199.54 $17.8 Million - $39.1 Million	196,106 Added 99.13%	393,941 $35.8 Million
Q2 2023 Aug 09, 2023	BUY	$155.98 - $172.65 $2.17 Million - $2.41 Million	13,931 Added 7.58%	197,835 $32 Million
Q1 2023 May 09, 2023	BUY	$132.34 - $159.14 $2.75 Million - $3.3 Million	20,765 Added 12.73%	183,904 $29.3 Million
Q4 2022 Feb 13, 2023	SELL	$102.55 - $135.33 $653,346 - $862,187	-6,371 Reduced 3.76%	163,139 $22.1 Million
Q3 2022 Oct 27, 2022	BUY	$95.28 - $116.93 $77,367 - $94,947	812 Added 0.48%	169,510 $16.9 Million
Q2 2022 Aug 01, 2022	BUY	$103.24 - $121.81 $205,344 - $242,280	1,989 Added 1.19%	168,698 $18.8 Million
Q1 2022 May 11, 2022	SELL	$93.1 - $112.54 $1.12 Million - $1.36 Million	-12,051 Reduced 6.74%	166,709 $18.5 Million
Q4 2021 Feb 11, 2022	BUY	$95.88 - $117.08 $2.75 Million - $3.36 Million	28,660 Added 19.09%	178,760 $20 Million
Q3 2021 Nov 10, 2021	BUY	$84.42 - $106.62 $1.61 Million - $2.04 Million	19,087 Added 14.57%	150,100 $14.4 Million
Q2 2021 Aug 05, 2021	SELL	$67.66 - $84.76 $78,891 - $98,830	-1,166 Reduced 0.88%	131,013 $11 Million
Q1 2021 Apr 28, 2021	SELL	$67.06 - $75.82 $1.3 Million - $1.47 Million	-19,436 Reduced 12.82%	132,179 $8.91 Million
Q4 2020 Feb 04, 2021	SELL	$63.89 - $73.8 $276,324 - $319,185	-4,325 Reduced 2.77%	151,615 $10.6 Million
Q3 2020 Nov 10, 2020	BUY	$63.69 - $70.22 $1.04 Million - $1.15 Million	16,388 Added 11.74%	155,940 $10.8 Million
Q2 2020 Aug 07, 2020	SELL	$58.54 - $67.94 $54,383 - $63,116	-929 Reduced 0.66%	139,552 $9.14 Million
Q1 2020 May 13, 2020	SELL	$49.46 - $64.78 $2.42 Million - $3.17 Million	-48,932 Reduced 25.83%	140,481 $8.46 Million
Q4 2019 Feb 04, 2020	SELL	$49.86 - $58.26 $594,580 - $694,750	-11,925 Reduced 5.92%	189,413 $11 Million
Q3 2019 Nov 08, 2019	SELL	$47.54 - $53.43 $1.3 Million - $1.46 Million	-27,324 Reduced 11.95%	201,338 $10.4 Million
Q2 2019 Aug 13, 2019	SELL	$46.79 - $52.47 $3.56 Million - $3.99 Million	-76,121 Reduced 24.98%	228,662 $11.7 Million
Q1 2019 May 08, 2019	SELL	$46.36 - $52.63 $11,219 - $12,736	-242 Reduced 0.08%	304,783 $15.9 Million
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $1.74 Million - $1.97 Million	41,786 Added 15.87%	305,025 $14.1 Million
Q3 2018 Nov 01, 2018	SELL	$46.76 - $51.24 $214,347 - $234,884	-4,584 Reduced 1.71%	263,239 $12.4 Million
Q2 2018 Aug 08, 2018	BUY	$44.29 - $50.42 $1.69 Million - $1.92 Million	38,165 Added 16.62%	267,823 $12.4 Million
Q1 2018 May 08, 2018	SELL	$48.49 - $58.14 $165,593 - $198,548	-3,415 Reduced 1.47%	229,658 $11.3 Million
Q4 2017 Feb 02, 2018	BUY	$47.53 - $53.73 $290,883 - $328,827	6,120 Added 2.7%	233,073 $12.5 Million
Q3 2017 Nov 13, 2017	BUY	$41.15 - $49.22 $9.34 Million - $11.2 Million	226,953	226,953 $10.9 Million

Others Institutions Holding NVO

# of Institutions

1,953

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $230B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account